Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses

Main Article Content

Peramachi Palanivelu

Abstract

Aim: To analyze spike proteins of Severe Acute Respiratory Syndrome (SARS)-related coronaviruses (CoVs) for their conserved motifs, Receptor-Binding  Domain (RBD), Receptor Binding Motif (RBM) of SARS-CoV (CoV-1), SARS-CoV-2, Middle East Respiratory Syndrome (MERS)-CoV and their relationship to the bat, pangolin and palm civet-CoVs as possible intermediate hosts.

Study Design: Multiple sequence analysis (MSA) of spike proteins of different SARS-CoVs were studied using Clustal Omega and ExPASy tools.

Methodology: Bioinformatics, SDM and X-ray crystallographic data of the spike proteins from different CoVs including the current epidemic causing SARS-CoV-2 were analyzed. The advanced version of Clustal Omega was used for protein sequence analysis of different spike proteins from various CoVs and ExPASy tool was used for pI analysis.

Results: Spike proteins in coronaviruses play important roles in mediating receptor binding, membrane fusion, and viral entry into human cells. Furthermore, nowadays all the vaccine development programmes are mainly focused on the SARS-CoV-2 spike protein only, as it plays the crucial, first step in the infection process. Therefore, the spike proteins of the SARS-related coronaviruses, the main determinant of coronavirus host specificity, are analyzed for their conserved motifs, RBD, RBM, etc. The recent epidemic causing strain, SARS-CoV-2, showed 2 dipeptide deletions and 4 peptide insertions ranging from tetra- to hepta-peptides in its spike protein as compared to its predecessor CoV-1. Most of the insertions are also found in the bat and pangolin CoVs except one unique tetrapeptide. The RBM region shows that the bats, pangolins and CoV-2 exhibit very similar to identical sequences. The overall analyses show that the latest SARS-CoV-2 is related to bats and more to pangolin-CoVs suggesting that the pangolins could be possibly the intermediate host. On the other hand, it is found that palm civet RBM sequences are highly related to CoV-1 and not CoV-2. Possibly the novel CoV-2 would have taken three insertions from bats and/or pangolins and the fourth insertion –PRRA- which is unique to SARS-CoV-2 is critically placed just in the S1/S2 cleavage region. The recently discovered G614 mutation (D614→G) in CoV-2, the most prevalent form in the global pandemic now, is found near the RBD towards the C-terminal. Placement of the unique tetrapeptide in the S1/S2 loop region and replacement with more positive charges on the spike protein which resulted in marked increase in the basicity of the SARS-CoV-2 spike protein may, possibly result in significant effects on the structure and function of the protein, possibly leading to rapid transmission.

Conclusions: RBD and RBM regions of the spike proteins of SARS-CoV-1 and palm civet show very close identity to each other whereas the SARS-CoV-2, pangolin- and bat-CoVs exhibit very close identities in their RBD and RBM regions. The two crucial modifications in the spike protein of SARS-CoV-2, viz. a marked increase in the basicity of the protein and the insertion of a dibasic tetrapeptide (–PRRA-) at the critical S1/S2 cleavage point possibly make it to bind to the ACE2 receptor with higher affinity and get it cleaved by the host proteases more efficiently with subsequent effective internalization of the viral genome.

Keywords:
Coronaviruses, Severe Acute Respiratory Syndrome, SARS-CoV-1, MERS-CoV, SARS-CoV-2, Bat-CoV, Pangolin-CoVs, Palm civet-CoVs.

Article Details

How to Cite
Palanivelu, P. (2020). Analyses of the Spike Proteins of Severe Acute Respiratory Syndrome-Related Coronaviruses. Microbiology Research Journal International, 30(8), 32-50. https://doi.org/10.9734/mrji/2020/v30i830249
Section
Original Research Article

References

Estola T. Coronaviruses, a new group of animal RNA viruses. Avian Dis. 1970;14: 330–336.

Kahn JS, McIntosh K (November). History and recent advances in coronavirus discovery. Pediatr. Infect Dis J. 2005; 24(11 Suppl):S223–7.

WHO; 2004). Summary of probable SARS cases with onset of illness. Available:https://www.who.int/csr/sars/country/table2004_04_21/en/ November 2002 to 31 July 2003.

MERS-CoV worldwide overview. European Centre for Disease Prevention and Control. Available:www.ecdc.europa.eu

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest. 2020;130: 2620–2629. DOI: 10.1172/JCI137244

Yeager CL, Ashmun RA, Williams RK et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature.1992; 357:420–422.

Hofmann H, Pyrc K, van der Hoek L et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci. USA. 2005;102:7988–7993.

Li W, MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426: 450-454.

Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495: 251–254.

Wu F, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579:265–269.

Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In Maier HJ, Bickerton E, Britton P, editors. Coronaviruses. Met Mol Biol. 1282. Springer. 2015;1–23. DOI: 10.1007/978-1-4939-2438-7_1

Watanabe Y, Joel D, Allen JD, Wrapp D, McLellan JS, Crispin M. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020; 369, 330–333.

Bestle D, Heindl MR, Limburg H, Lam van TV, Pilgram O, Moulton H, Stein DA, et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci Alliance. 2020;3(9);e202000786(1-14). Available:https://doi.org/10.26508/lsa.202000786.

Liu P , Jiang JZ , Wan XF, Hua Y, Li L, Zhou J, Wang X, Hou F, Chen J, Zou J, Chen J. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?. PLoS Pathog. 2019;16(5): e1008421.https://doi.org/10.1371/journal.ppat.1008421.

Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, Tong YG, et al. Identifying SARS-CoV-2-related corona-viruses in Malayan pangolins. Nature. 2020;583: 282-285.

Korber B, W.M. Fischer, S. Gnanakaran, H. Yoon, J. Theiler, W. Abfalterer et al.Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. Available:https://doi.org/10.1016/j.cell.2020.06.043 26-6-2020.

Vickers C, Paul Hales, Virendar Kaushik, Larry Dick, James Gavin, Jin Tang, Kevin Godbout et al. Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase. J Biol Chem. 2002;277: 14838–14843.

Grober AS, Vey M, Angliker H, Shawl E, Thomas G, Roberts C, Kienk HD, et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 1992;11:2407-2414.

Hoffmann M, Kleine-Weber H, PÖhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Molecular Cell. 2020;78: 779–784.

Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020; 581:215-220.

Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M, Pascarella S.. Sars-CoV-2 Envelope and Membrane Proteins: Structural differences Linked to Virus Characteristics? BioMed Res. Int. 2020;2020: 1-6.

Zhu X, Qi Liu, Lanying Du, Lu Lu, Shibo Jiang. Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis. (Emerging infectious respiratory disease & the 10th Anniversary of SARS Epidemics) . 2013; 5(Supplement 2). DOI:10.3978/j.ISSN.2072-1439.2013.06.06

Yi CE, Ba L, Zhang L, et al. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determines viral entry and immunogenicity of a major neutralizing domain. J Virol. 2005;79: 11638-46.

Keck JG, Makino S, Soe LH et al. RNA recombination of coronavirus. Adv Exp Med Biol. 1987; 218:99–107.

Liao C, Lai MMC. RNA Recombination in a Coronavirus: Recombination between Viral Genomic RNA and Transfected RNA Fragments. J Virol. 1992;66: 6117-6124.

Palanivelu P. Analyses of Homing Endonucleases and Mechanism of Action of CRISPR-Cas9 HNH Endonucleases. Int J Biochem Res Rev. 2020;29:1-25.

Palanivelu P. Eukaryotic multi-subunit DNA dependent RNA Polymerases: An Insight into their Active Sites and Catalytic Mechanism. In: Advances and Trends in Biotechnology and Genetics. 2019;1:1-38. SCIENCEDOMAIN International Book Publishers, UK, Print ISBN: 978-93-89246-59-9. DOI: 10.9734/bpi/atbg/v1;2019.